Denise Yu
- Oncology top 5%
- Molecular Biology
- Cellular and Molecular Neuroscience top 5%
- Endocrinology, Diabetes and Metabolism top 5%
- Cancer Research top 10%
- Co-authors
- Mark D. GorrellGeoffrey W. McCaughanCatherine A. AbbottXin Maggie WangMark KirbyErica WoollattGrant R. SutherlandW. Bret Church
- Topics
- Peptidase Inhibition and Analysis (15 papers)Neuropeptides and Animal Physiology (10 papers)Neuroblastoma Research and Treatments (7 papers)
- Partner nations
- AustraliaUnited StatesCanada
In The Last Decade
Denise Yu
28 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 94
- Oncology 891
- Molecular Biology 582
- Cellular and Molecular Neuroscience 438
- Endocrinology, Diabetes and Metabolism 380
- Cancer Research 297
Countries citing papers authored by Denise Yu
This map shows the geographic impact of Denise Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Denise Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Denise Yu more than expected).
Fields of papers citing papers by Denise Yu
This network shows the impact of papers produced by Denise Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Denise Yu. The network helps show where Denise Yu may publish in the future.
Co-authorship network of co-authors of Denise Yu
This figure shows the co-authorship network connecting the top 25 collaborators of Denise Yu. A scholar is included among the top collaborators of Denise Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Denise Yu. Denise Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 9 | |
| 2 | 84 | |
| 3 | 31 | |
| 4 | 36 | |
| 5 | 4 | |
| 6 | 16 | |
| 7 | 17 | |
| 8 | 28 | |
| 9 | 27 | |
| 10 | 58 | |
| 11 | 19 | |
| 12 | 41 | |
| 13 | 12 | |
| 14 | 139 | |
| 15 | 52 | |
| 16 | 67 | |
| 17 | 8 | |
| 18 | 22 | |
| 19 | 149 | |
| 20 | 217 |
About Denise Yu
Denise Yu is a scholar working on Oncology, Cancer Research and Cellular and Molecular Neuroscience, having authored 28 papers that have together received 1.4k indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (15 papers), Neuropeptides and Animal Physiology (10 papers) and Neuroblastoma Research and Treatments (7 papers). The work is most often cited by research in Oncology (891 citations), Cellular and Molecular Neuroscience (438 citations) and Endocrinology, Diabetes and Metabolism (380 citations). Denise Yu has collaborated with scholars based in Australia, United States and Canada. Frequent co-authors include Mark D. Gorrell, Geoffrey W. McCaughan, Catherine A. Abbott, Xin Maggie Wang, Mark Kirby, Erica Woollatt, Grant R. Sutherland, W. Bret Church, Michelle Haber and Murray D. Norris. Their work appears in journals such as Nature Communications, PLoS ONE and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.